A Phase 1 Study of BMF-500 in Adults With Acute Leukemia
Clinical trial NCT05918692 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05918692
- Sponsor
- Biomea Fusion Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-26
- Primary completion
- 2026-04-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.